Literature DB >> 28666809

Bio-based Industries Joint Undertaking: The catalyst for sustainable bio-based economic growth in Europe.

Philippe Mengal1, Marcel Wubbolts2, Eleni Zika3, Ana Ruiz4, Dieter Brigitta4, Agata Pieniadz4, Sarah Black5.   

Abstract

This article discusses the preparation, structure and objectives of the Bio-based Industries Joint Undertaking (BBI JU). BBI JU is a public-private partnership (PPP) between the European Commission (EC) and the Bio-based Industries Consortium (BIC), the industry-led private not-for-profit organisation representing the private sectors across the bio-based industries. The model of the public-private partnership has been successful as a new approach to supporting research and innovation and de-risking investment in Europe. The BBI JU became a reality in 2014 and represents the largest industrial and economic cooperation endeavour financially ever undertaken in Europe in the area of industrial biotechnologies. It is considered to be one of the most forward-looking initiatives under Horizon 2020 and demonstrates the circular economy in action. The BBI JU will be the catalyst for this strategy to mobilise actors across Europe including large industry, small and medium-sized enterprises (SMEs), all types of research organisations, networks and universities. It will support regions and in doing so, the European Union Member States and associated countries in the implementation of their bioeconomy strategies.
Copyright © 2017 Elsevier B.V. All rights reserved.

Keywords:  BBI JU programme office; Bio-based; Bio-based Industries Consortium; Bio-economy; Biorefinery; Circular economy; European Commission; Horizon 2020; Innovation; Joint undertaking; Public-private partnership

Mesh:

Year:  2017        PMID: 28666809     DOI: 10.1016/j.nbt.2017.06.002

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  3 in total

1.  Friends or foes? A compatibility assessment of bioeconomy-related Sustainable Development Goals for European policy coherence.

Authors:  Tévécia Ronzon; Ana I Sanjuán
Journal:  J Clean Prod       Date:  2020-05-01       Impact factor: 9.297

2.  Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe.

Authors:  Renske M T Ten Ham; Jarno Hoekman; Anke M Hövels; Andre W Broekmans; Hubert G M Leufkens; Olaf H Klungel
Journal:  Mol Ther Methods Clin Dev       Date:  2018-10-11       Impact factor: 6.698

3.  Monitoring Intracellular Metabolite Dynamics in Saccharomyces cerevisiae during Industrially Relevant Famine Stimuli.

Authors:  Steven Minden; Maria Aniolek; Christopher Sarkizi Shams Hajian; Attila Teleki; Tobias Zerrer; Frank Delvigne; Walter van Gulik; Amit Deshmukh; Henk Noorman; Ralf Takors
Journal:  Metabolites       Date:  2022-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.